NEU neuren pharmaceuticals limited

Ann: Final Director's Interest Notice - T Scott, page-4

  1. 1,357 Posts.
    lightbulb Created with Sketch. 567
    I would love that but its not an orphan indication is it?

    Thinking it through, its an interesting proposition because its not a genetic condition. It is generally associated with a head impact, so the numbers can vary wildly, based on how many head impacts there are that cause TBI.

    Some years the numbers may be small, some years they may be big - I wonder how you categorise that. I guess similar to cancer drugs and is that done on average prevalence?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.612B
Open High Low Value Volume
$13.20 $13.36 $12.82 $4.627M 354.8K

Buyers (Bids)

No. Vol. Price($)
1 7585 $12.96
 

Sellers (Offers)

Price($) Vol. No.
$13.03 3344 2
View Market Depth
Last trade - 16.10pm 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.